Gline Matthew

Gline Matthew is listed in filings as CEO at Roivant Sciences Ltd. - Common Shares. This profile follows SEC Form 4 activity through Apr 20, 2026, including purchase activity and sale activity. Recent filings connect the profile to Roivant Sciences Ltd. - Common Shares (ROIV). The current snapshot covers public activity from May 22, 2025 to Apr 20, 2026. Reported amounts are shown as $120.8K to $28.8M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.